Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Demopoulos, H
The article reports a public regulatory development
The study "Liraglutide versus placebo as an adjunct to glucose-lowering therapy in patients with type 2 diabetes and moderate renal failure" (LIRA-RENAL) did not demonstrate a benefit of liraglutide in lowering eGFR, although the duration of the study (26 weeks) may have been insufficient to show an effect
PMID: 7766968
The antidiabetic effect and potential mechanisms of natural polysaccharides based on the regulation of gut microbiota
Promotes liver function and detoxification, ensuring your body processes and eliminates fats and toxins effectively
US$ 29.94
US$ 22.78
US$ 26.99
US$ 24.13
US$ 28.65
